This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of chiral molecules. Its structure, featuring a diphenylethyl backbone and a methanesulfonamide group, makes it a valuable intermediate in the production of enantiomerically pure compounds. These compounds are often explored for their potential as active pharmaceutical ingredients (APIs) in drugs targeting neurological disorders, including Parkinson's disease and other conditions requiring dopaminergic modulation. Additionally, its chiral nature is leveraged in asymmetric synthesis, where it serves as a ligand or catalyst to induce stereoselectivity in chemical reactions, enhancing the efficiency and specificity of drug manufacturing processes.